We were able to define a valid threshold for the immunohistochemical evaluation of Mcm2, as 40% had a good discriminatory power for recurrence rate (P<0.001).
In order to test whether setting a valid threshold for methylation change yields enhanced functional enrichment results, an analysis is done for varying thresholds between 0.05 (5%) and 0.5 (50%) focusing on inverse correlation between expression and methylation.
In this sense, B-Value threshold in methylation experiments is an issue that needs to be seriously addressed; hence setting a valid threshold for methylation change between two conditions may be helpful in obtaining more accurate list of significantly methylated or unmethylated genes.
Firstly, several unverified assumptions potentially limit the interpretation of adherence by using the medication possession ratio, i.e. that 1) patients are actually taking drugs every time they refill their medications 2) patients do not receive medication outside the hospital pharmacy network; and 3) the MPR threshold of 0.8 is a valid threshold for adherence.
Moreover, while increasing the number of samples improves the analysis confidence of the experiment, optimal results with respect to disease-related pathways were obtained after setting a valid threshold for change in methylation level, which is defined by considering the inverse correlation gain above and below of a certain threshold.
However, the valid threshold values for termination iteration in the OMP and FISTA algorithms always depend on the power of noise or the sparsity of signal, which are both quite difficult to estimate beforehand in practical applications.
There are two criteria for deriving a valid threshold value T i for each feature.
Because previous studies (11– 17) have analyzed different CpG sites and relied on different techniques to determine the methylation status of the BRCA1 promoter, it is difficult to define a universally valid absolute threshold for gene silencing.
Other methodological strengths include the use of multiple imputation techniques to account for randomly missing data, sensitivity analyses to help determine thresholds for valid Actiheart data, adjustment for a range of potential confounders, and testing for differences by independent travel modes and sex.
Therefore, the reported MTV deviations of PSF reconstructions are strictly speaking only valid for threshold-based delineation methods.
